BiotechTube
Home/CalciMedica/Kenneth Stauderman, Ph.D.
KS

Kenneth Stauderman, Ph.D.

Co-founder & Chief Scientific Officer

CalciMedica

Therapeutic Areas

Acute Inflammatory DiseasesImmunology

CalciMedica Pipeline

DrugIndicationPhase
Auxora (zegocractin)Acute Pancreatitis (AP) with Systemic Inflammatory Response Syndrome (SIRS)Phase 2b

Leadership Team at CalciMedica

AR
A. Rachel Leheny, Ph.D.
Chief Executive Officer
SH
Sudarshan Hebbar, M.D.
Chief Medical Officer
View full CalciMedica profile